Gain Unrivalled Insights Into GBM-Specific Clinical Trial Rationale to Keep Ahead of the Curve

Time: 2:00 pm
day: Conference Day 1


  • Overview of the updated response criteria for glioblastomas and IDH-mutated gliomas: RANO 2.0
  • Sharing therapeutic modality-specific advice on clinical trial design
  • Analyzing novel endpoints for glioma trials